Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Hikma Pharmaceuticals PLC

www.hikma.com

Latest From Hikma Pharmaceuticals PLC

Stock Scan December 2017: Teva Stick, Valeant Carrot Spur Generics Revival

The end-of-year stock valuations across Big Pharma jumped nearly 3% in December led by financial reassurances at Valeant and gleeful shareholder reaction to ceremonial employee sacrifices at Teva.

Generic Drugs Strategy

Deal Watch: Boehringer's Busy End Of Year Includes Deals With Roche, Autifony

The German pharma options potassium channel modulator technology from Autifony and partners with Roche on immunological approaches to irritable bowel syndrome. Roche unveils discovery pacts with Confo and DiCE.

Deals Business Strategies

Stock Scan November 2017: Generics get volatile

Generic drug producers endured very mixed fortunes on the world's stock markets, with firms ending November at opposite ends of Scrip's Stock Scan monthly league table.

Growth Sales & Earnings

OTCs Launched On Fluticasone ANDAs, Lidocaine In Monograph

Innovus entering OTC fluticasone market in November; and Rising Biosciences prepares topical OTC pain relief.

Consumer Respiratory
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • Hikma Pharmaceuticals PLC
  • Senior Management
  • Said Darwazah, Chmn. & CEO
    Khalid Nabilsi, CFO
    Bassam Kanaan, Chief Strategy & Corp. Dev. Officer
  • Contact Info
  • Hikma Pharmaceuticals PLC
    Phone: (44) 20 7399 2760
    1 New Burlington Pl.
    London, W1S 2HR
    UK
Advertisement
Advertisement
UsernamePublicRestriction

Register